Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Further ahead in development (applying for regulatory approval in Q1 2025)
These are powerful pharmacological tools with real side effect profiles, and they're best deployed when the metabolic case for intervention is clear
In a small number of cases, you may experience symptoms that are a bit more serious, such as blurred vision, low blood sugar, or a change in your blood pressure
Phase 2 Trial of Retatrutide for Obesity
US$ 27.13
US$ 29.69
US$ 24.44
US$ 28.77
US$ 23.91
US$ 25.65
US$ 22.30
US$ 25.85
US$ 28.53
US$ 26.60
US$ 28.59
